|
Age
| |
0.782
|
–
|
–
|
|
Gender
|
0.8 (0.5–1.3)
|
0.412
|
–
|
–
|
|
Education
|
|
No formal
|
1.0 (0.5–2.3)
|
0.921
|
–
|
–
|
|
Primary
|
1.9 (0.9–4.2)
|
0.078
|
–
|
–
|
|
Secondary
|
1.5 (0.7–3.3)
|
0.272
|
–
|
–
|
|
Tertiary
| | | | |
|
Occupation
|
|
Unemployed/retired
|
0.9 (0.6–1.4)
|
0.832
|
–
|
–
|
|
Employed
| | | | |
|
Duration of hypertension, year
|
|
Unknown
|
0.6 (0.3–1.5)
|
0.317
|
–
|
–
|
|
≥5
|
1.3 (0.8–1.9)
|
0.284
|
–
|
–
|
|
<5
| | | | |
|
Duration of antihypertensive treatment, year
|
|
Unknown
|
0.9 (0.4–1.9)
|
0.897
|
–
|
–
|
|
≥5
|
1.2 (0.8–1.9)
|
0.342
|
–
|
–
|
|
<5
| | | | |
|
Control of blood pressure n = 390
|
|
Uncontrolled
|
1.8 (1.1–3.2)
|
0.032*
|
2.0 (1.1–3.7)
|
0.018*
|
|
Experience of medication side effects
|
1.9 (1.3–2.9)
|
0.001*
|
2.2 (1.4–3.3)
|
0.001*
|
|
Experience of physical symptoms due to hypertension
|
1.4 (0.9–2.1)
|
0.122
|
–
|
–
|
|
Presence of Co-morbidity
|
1.2 (0.8–1.7)
|
0.465
|
–
|
–
|
|
Taking of non-prescribed medications
|
1.7 (1.1–2.8)
|
0.042*
|
2.2 (1.2–3.8)
|
0.006*
|
|
Poor knowledge of risk factors related to HTN
|
0.7 (0.5–1.1)
|
0.140
|
–
|
–
|
|
Poor knowledge of HTN related complications
|
2.5 (1.4–4.3)
|
0.001*
|
2.4 (1.4–4.4)
|
0.003*
|
|
Poor knowledge of treatment benefit
|
1.5 (0.7–3.1)
|
0.324
|
–
|
–
|
|
Beliefs that BP medications are helpful in controlling BP
|
1.3 (0.7–2.3)
|
0.421
|
–
|
–
|
|
Accept hypertensive status
|
1.2 (0.7–2.0)
|
0.589
|
–
|
–
|
|
Perception of HTN gravity
|
1.1 (0.6–1.8)
|
0.838
|
–
|
–
|
|
Perception of HTN related complications gravity
|
1.2 (0.7–2.0)
|
0.526
|
–
|
–
|
|
Perception of patient-provider relationships
|
2.0 (0.8–4.9)
|
0.128
|
–
|
–
|
|
Lack of patient education performed in the healthcare facility
|
1.9 (1.3–2.9)
|
0.003*
|
1.7 (1.1–2.7)
|
0.023*
|
|
Perception of treatment cost
|
0.9 (0.6–1.6)
|
0.948
|
–
|
–
|
|
Healthcare facility accessible geographically
|
0.9 (0.6–1.5)
|
0.771
|
–
|
–
|
|
Unavailability of antihypertensive medications in the healthcare facilities
|
2.6 (1.3–5.2)
|
0.003*
|
2.8 (1.4–5.5)
|
0.003*
|
